Improved detection of multiple sclerosis gadolinium-enhancing lesions: 3D T1 Turbo-Spin-Echo Outperforms 3D T1 Turbo-Field Echo MRI
Authors:
- Pablo Naval-BaudinPNPablo Naval-Baudin
- William F Bermúdez BravoWBWilliam F Bermúdez Bravo
- Vanessa I Pineda-BorjaVPVanessa I Pineda-Borja
- Pablo Arroyo-PereiroPAPablo Arroyo-Pereiro
- Ignacio Martínez-ZalacaínIMIgnacio Martínez-Zalacaín
- Lucía RomeroLRLucía Romero
- Paloma MoraPMPaloma Mora
- Nahum CalvoNCNahum Calvo
- Sergio Martínez-YélamosSMSergio Martínez-Yélamos
- Mònica CosMCMònica Cos
- Albert Pons-EscodaAPAlbert Pons-Escoda
Preprint
Abstract
Objectives To compare the performance of 3D T1 turbo spin echo (3DT1TSE) and 3D T1 turbo field echo (3DT1TFE) MRI in detecting gadolinium-enhancing lesions in multiple sclerosis (MS). Methods We retrospectively analyzed 255 3T MRIs from MS patients, each including post-contrast 3DT1TSE and 3DT1TFE sequences. Two blinded readers independently assessed enhancing lesions per sequence. A consensus review, incorporating longitudinal imaging and additional sequences, served as the reference standard. Results The consensus identified 70 enhancing lesions in 31 patients. All 70 were visible on 3DT1TSE, while 64 (91%) were detectable on 3DT1TFE. Reader sensitivity was higher for 3DT1TSE (84% and 90%) than 3DT1TFE (45% and 40%) (p < 0.01). Inter-reader agreement was excellent for 3DT1TSE (ICC = 0.90) and moderate for 3DT1TFE (ICC = 0.69). Although false positives were more common with 3DT1TSE, they were readily excluded during consensus reading. In six patients, enhancing lesions were detected only on 3DT1TSE, with treatment escalation in two. Conclusion 3DT1TSE outperformed 3DT1TFE in sensitivity and reader agreement for enhancing lesion detection in MS. Incorporating 3DT1TSE into standard MRI protocols may improve disease activity assessment and clinical decision-making.Keywords
This publication has 28 references indexed in Scilit:
- The T1-dark-rim: A novel imaging sign for detecting smoldering inflammation in multiple sclerosisEuropean Journal of Radiology, 2024
- Post-contrast 3D T1-weighted TSE MR sequences (SPACE, CUBE, VISTA/BRAINVIEW, isoFSE, 3D MVOX): Technical aspects and clinical applicationsJournal Of Neuroradiology, 2020
- Multiple sclerosisNature Reviews Disease Primers, 2018
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaThe Lancet Neurology, 2018
- Brain health: time matters in multiple sclerosisMultiple Sclerosis and Related Disorders, 2016
- A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability ResearchJournal of Chiropractic Medicine, 2016
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trialsThe Lancet Neurology, 2013
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyThe Lancet Neurology, 2009
- Optimized T1‐weighted contrast for single‐slab 3D turbo spin‐echo imaging with long echo trains: Application to whole‐brain imagingMagnetic Resonance in Medicine, 2007
- Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imagingBrain, 1997